ATRA- Atara Biotherapeutics, Inc.

Name: Atara Biotherapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Atara Biotherapeutics, Inc. (ATRA) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. ATRA is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Panacea Innovation Ltd	1.32M	$11.05M	-
10%	Adiumentum Capital Fund I LP	377.2K	$3.15M	-
CEO	Nguyen Anhco	143.1K	$1.19M	-
?	Touchon Pascal	78.0K	$650.1K	-
Other	Grant-Huerta Yanina	52.0K	$434.1K	-

Activity

Buys and sells only

Transactions

10 filings · page 11

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 18, 2021	Koppikar Utpal76	Chief Financial Officer	Sell	3,616	$14.55	$52,612.80	-2.1%	-14.6%	-64.7%
May 18, 2021	Yarema Kristin	Chief Commercial Officer	Sell	761	$14.55	$11,072.55	-0.8%	-14.6%	-64.7%
May 17, 2021	Newell Joe85	Chief Operations Officer	Sell	3,500	$15.00	$52,500.00	-2.6%	-13.6%	-61.1%
Apr 5, 2021	Newell Joe85	Chief Operations Officer	Sell	655	$14.74	$9,654.70	-0.5%	-0.7%	-36.6%
Mar 26, 2021	Koppikar Utpal76	Chief Financial Officer	Sell	1,761	$14.58	$25,675.38	-1.0%	+12.0%	-36.5%
Mar 26, 2021	Newell Joe85	Chief Operations Officer	Sell	2,640	$14.58	$38,491.20	-1.9%	+12.0%	-36.5%
Mar 15, 2021	Newell Joe85	Chief Operations Officer	Sale+OE	7,000	$17.41	$121,870.00	-4.8%	-15.3%	-50.8%
Mar 2, 2021	Newell Joe85	Chief Operations Officer	Sell	1,665	$16.74	$27,872.10	-1.2%	-17.5%	-42.1%
Mar 2, 2021	Koppikar Utpal76	Chief Financial Officer	Sell	1,461	$16.74	$24,457.14	-0.8%	-17.5%	-42.1%
Mar 2, 2021	Touchon Pascal82	President And CEO	Sell	4,887	$16.74	$81,808.38	-1.3%	-17.5%	-42.1%

← PrevPage 11Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC